Summary
Eli Lilly & Company (LLY) filed an 8-K on October 26, 2021, to report its financial results for the third quarter ended September 30, 2021. The report primarily directs investors to an attached press release (Exhibit 99.1) for detailed financial performance and operational updates. This filing serves as the official notification of these results to the market, without triggering the same level of regulatory scrutiny as if the information were 'filed' under Section 18 of the Exchange Act.
Key Highlights
- 1The 8-K filing is primarily to furnish the company's third-quarter 2021 earnings press release, dated October 26, 2021.
- 2Investors are directed to Exhibit 99.1, the press release, for unaudited financial results for the quarter ended September 30, 2021.
- 3The information is being furnished under Item 2.02 (Results of Operations and Financial Condition).
- 4The filing specifies that the information furnished is not deemed 'filed' for purposes of Section 18 of the Exchange Act, limiting certain liabilities.
- 5This filing does not contain new financial statements or substantive operational disclosures beyond what is included in the press release.
- 6The interactive data file for the cover page is also included as an exhibit.